J Scott Overcash MD FACEP
Emergency Physician, Principal Investigator, Medical Director
Join to View Full Profile
5555 Grossmont Center DrLa Mesa, CA 91942
Phone+1 619-740-4401
Fax+1 619-740-3972
Dr. Overcash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. J. Scott Overcash is an Emergency Medicine and Clinical Research physician in San Diego, CA.
He is affiliated with Sharp Healthcare and Velocity Clinical Research. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 16 years.
Education & Training
University of North Carolina HospitalsResidency, Emergency Medicine, 2001 - 2004
University of North Carolina at Chapel Hill School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2008 - 2025
NC State Medical License 2001 - 2025
FL State Medical License 2004 - 2012
HI State Medical License 2003 - 2003
American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials.Thomas L Holland, Andrew F Shorr, J Scott Overcash, Marc Engelhardt, Mark Jones
The Journal of Antimicrobial Chemotherapy. 2025-03-28 - 3 citationsLong-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.Lindsey R Baden, Hana M El Sahly, Brandon Essink, Dean Follmann, Gregory Hachigian
Nature Communications. 2024-08-29 - 9 citationsEfficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function.Alex D Hakim, Mustafa Awili, Hollis R O'Neal, Omar Siddiqi, Naseem Jaffrani
Clinical and Experimental Immunology. 2023-10-13
Journal Articles
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin InfectionsG. Ralph Corey, M.D., Heidi Kabler, M.D., Purvi Mehra, M.D., Sandeep Gupta, M.D., J. Scott Overcash, M.D., Ashwin Porwal, M.D., Philip Giordano, M.D., Christopher Luca..., The New England Journal of Medicine, 6/5/2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
